Skip to main content
OpenTrials
Completed

NCT Number: NCT04585360

Psychiatric Manifestations Associated With Behcet's Disease

The psychoBehçet'study is aimed at evaluating the psychological and neurocognitive symptoms in 25 consecutive patients followed for Behçet's disease. This is a monocentric, observational, non interventional study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Behçet's Disease Anxiety Disorders Behavior Behavioral Symptoms Behcet Syndrome Cardiovascular Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Depression Eye Diseases Fatigue Genetic Diseases, Inborn Hereditary Autoinflammatory Diseases Mental Disorders Mouth Diseases Panuveitis Pathological Conditions, Signs and Symptoms Psychiatric Disorders Signs and Symptoms Skin Diseases Skin Diseases, Genetic Skin Diseases, Vascular Skin and Connective Tissue Diseases Stomatognathic Diseases Uveal Diseases Uveitis Uveitis, Anterior Vascular Diseases Vasculitis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Internal medecine department

Le Kremlin-Bicêtre, Val de Marne, 94275, France

About this study

Patients will be evaluated during a day-care facility for Behçet's disease activity together with evaluation of anxiety and depression symptoms (SCL90-R and MINI assessments), fatigue (MFI) and quality of life (SF36).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult male or female
  • Regular follow-up in the internal medicine department of Bicetre hospital
  • Diagnosed with Behçet's disease

Exclusion criteria

  • Refusal to participate in the study
  • Poor command of the French language
  • Patients under legal protection
  • Pregnant woman

Treatment and study plan

Questionnaires evaluating anxiety and depression symptoms, tiredness, and quality of life

Other

Realization of specific questionnaires evaluating:

  • psychiatric symptoms (self-assessment according to the SLC-90R questionnaire and hetero-assessment by the internist doctor of the center according to the M.I.N.I. questionnaire)
  • fatigue (Multidimensional Fatigue Inventory (MFI-20), French version, in self-assessment)
  • quality of life (SF36 self-assessment questionnaire)

Primary outcomes

  1. SCL90-R questionnaire

    Time frame: Inclusion visit

    Anxiety/depression symptoms questionnaire

Secondary outcomes

  1. MINI questionnaire

    Time frame: Inclusion visit

    Anxiety/depression symptoms questionnaire

  2. Multidimensional Fatigue Inventory (MFI-20) questionnaire

    Time frame: Inclusion visit

    Tiredness assessment

  3. SF36 questionnaire

    Time frame: Inclusion visit

    Quality of life

  4. BSAS/BDCAF evaluation

    Time frame: Inclusion visit

    Behçet's disease activity

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Acronym: PSYCHO-B7

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Oct 14, 2020
Registry last updated
Feb 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.